Back during the spring of 2020, in the earliest dark days of the Wuhan “pandemic,” astute data analysts noticed a significant pattern that might offer hope of stemming the threat posed by the disease. While the virus was rampant and spreading rapidly throughout the world’s most advanced cultures, it was not nearly as prolific in the third world, particularly in subtropical and tropical regions where Malaria is widespread. It didn’t take them long to establish a strong causal relation between usage of the anti-parasitic drug Hydroxychloroquine (HCQ) and a resistance to contracting the virus, as well as rapid, nearly miraculous...
